Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.12
+0.33 (0.99%)
Nov 21, 2024, 1:05 PM EST - Market open
HRMY Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for HRMY stock have an average target of 47, with a low estimate of 28 and a high estimate of 59. The average target predicts an increase of 41.93% from the current stock price of 33.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HRMY stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $51 → $58 | Buy | Maintains | $51 → $58 | +75.15% | Oct 30, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $56 → $59 | Buy | Reiterates | $56 → $59 | +78.17% | Oct 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +57.03% | Oct 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +57.03% | Oct 29, 2024 |
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +20.79% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
725.36M
from 582.02M
Increased by 24.63%
Revenue Next Year
856.23M
from 725.36M
Increased by 18.04%
EPS This Year
2.34
from 2.13
Increased by 10.08%
EPS Next Year
3.31
from 2.34
Increased by 41.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 753.1M | 928.3M | 1.2B | ||
| Avg | 725.4M | 856.2M | 1.0B | ||
| Low | 689.5M | 774.9M | 799.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 29.4% | 28.0% | 38.7% | ||
| Avg | 24.6% | 18.0% | 19.6% | ||
| Low | 18.5% | 6.8% | -6.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.71 | 4.89 | 6.32 | |
| Avg | 2.34 | 3.31 | 4.70 | |
| Low | 1.90 | 1.78 | 3.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 27.2% | 108.7% | 91.2% | |
| Avg | 10.1% | 41.0% | 42.2% | |
| Low | -10.7% | -23.9% | 1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.